# Veea Inc.: financial statements, quarterly VEEA · Nasdaq · CIK 1840317 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/veea.md) · [Financials](/companies/veea/financials.md) · [Filings](/companies/veea/filings.md) · [Insiders](/companies/veea/insiders.md) Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/veea/financials.md?period=annual). ## Income statement | Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [9.0](/filings/0001213900-24-100269.md) | [0.0 d](/filings/0001213900-25-032215.md) | [0.0](/filings/0001213900-25-046124.md) | [0.0](/filings/0001213900-25-078177.md) | [0.1](/filings/0001213900-25-111013.md) | [0.0 d](/filings/0001213900-26-043667.md) | [0.0](/filings/0001213900-26-057059.md) | [0.1](/filings/0001213900-26-087946.md) | [0.1](/filings/0001213900-25-111013.md) | [(0.0) d](/filings/0001213900-26-043667.md) | [0.2](/filings/0001213900-26-057059.md) | [0.2](/filings/0001213900-26-087946.md) | | Cost of revenue | $m | [0.0](/filings/0001213900-24-100269.md) | [0.4 d](/filings/0001213900-25-032215.md) | [0.0](/filings/0001213900-25-046124.md) | [0.0](/filings/0001213900-25-078177.md) | [0.0](/filings/0001213900-25-111013.md) | [0.0 d](/filings/0001213900-26-043667.md) | [0.0](/filings/0001213900-26-057059.md) | [0.0](/filings/0001213900-26-087946.md) | [0.1](/filings/0001213900-25-111013.md) | [0.0 d](/filings/0001213900-26-043667.md) | [0.0](/filings/0001213900-26-057059.md) | [0.0](/filings/0001213900-26-087946.md) | | Gross profit | $m | [9.0](/filings/0001213900-24-100269.md) | [(0.4) d](/filings/0001213900-25-032215.md) | [0.0](/filings/0001213900-25-046124.md) | [0.0](/filings/0001213900-25-078177.md) | [0.0](/filings/0001213900-25-111013.md) | [0.0 d](/filings/0001213900-26-043667.md) | [0.0](/filings/0001213900-26-057059.md) | [0.1](/filings/0001213900-26-087946.md) | [0.1](/filings/0001213900-25-111013.md) | [(0.0) d](/filings/0001213900-26-043667.md) | [0.2](/filings/0001213900-26-057059.md) | [0.1](/filings/0001213900-26-087946.md) | | Research and development | $m | [0.2](/filings/0001213900-24-100269.md) | [0.0 d](/filings/0001213900-25-032215.md) | [0.1](/filings/0001213900-25-046124.md) | [0.7](/filings/0001213900-25-078177.md) | [0.4](/filings/0001213900-25-111013.md) | [0.2 d](/filings/0001213900-26-043667.md) | [0.2](/filings/0001213900-26-057059.md) | [0.1](/filings/0001213900-26-087946.md) | [(0.0) d](/filings/0001213900-25-111013.md) | [0.2 d](/filings/0001213900-26-043667.md) | [0.1](/filings/0001213900-26-057059.md) | [0.1](/filings/0001213900-26-087946.md) | | Operating income | $m | [3.4](/filings/0001213900-24-100269.md) | [(5.1) d](/filings/0001213900-25-032215.md) | [(6.1)](/filings/0001213900-25-046124.md) | [(6.8)](/filings/0001213900-25-078177.md) | [(57.5)](/filings/0001213900-25-111013.md) | [(14.2) d](/filings/0001213900-26-043667.md) | [(5.8)](/filings/0001213900-26-057059.md) | [(4.9)](/filings/0001213900-26-087946.md) | [(4.7)](/filings/0001213900-25-111013.md) | [(3.5) d](/filings/0001213900-26-043667.md) | [(5.0)](/filings/0001213900-26-057059.md) | [(7.1)](/filings/0001213900-26-087946.md) | | Interest expense | $m | [1.8](/filings/0001213900-24-100269.md) | [0.9 d](/filings/0001213900-25-032215.md) | [0.5](/filings/0001213900-25-046124.md) | [0.4](/filings/0001213900-25-078177.md) | [0.5](/filings/0001213900-25-111013.md) | [0.5 d](/filings/0001213900-26-043667.md) | [0.9](/filings/0001213900-26-057059.md) | [0.4](/filings/0001213900-26-087946.md) | [0.4](/filings/0001213900-25-111013.md) | [0.4 d](/filings/0001213900-26-043667.md) | [0.8](/filings/0001213900-26-057059.md) | [0.6](/filings/0001213900-26-087946.md) | | Net income | $m | [2.0](/filings/0001213900-24-100269.md) | [(6.2) d](/filings/0001213900-25-032215.md) | [(6.5)](/filings/0001213900-25-046124.md) | [(7.3)](/filings/0001213900-25-078177.md) | [(33.3)](/filings/0001213900-25-111013.md) | [(0.9) d](/filings/0001213900-26-043667.md) | [4.3](/filings/0001213900-26-087946.md) | [(7.4)](/filings/0001213900-26-087946.md) | [1.4](/filings/0001213900-25-111013.md) | [(4.9) d](/filings/0001213900-26-043667.md) | [(4.7)](/filings/0001213900-26-087946.md) | [(4.0)](/filings/0001213900-26-087946.md) | | Diluted EPS | $ per share | [0.12](/filings/0001213900-24-100269.md) | not reported | [(0.31)](/filings/0001213900-25-046124.md) | [(0.34)](/filings/0001213900-25-078177.md) | [(1.49)](/filings/0001213900-25-111013.md) | not reported | [0.12](/filings/0001213900-26-057059.md) | [(0.19)](/filings/0001213900-26-087946.md) | [0.03](/filings/0001213900-25-111013.md) | not reported | [(0.09)](/filings/0001213900-26-057059.md) | [(0.08)](/filings/0001213900-26-087946.md) | | Basic EPS | $ per share | [0.12](/filings/0001213900-24-100269.md) | not reported | [(0.31)](/filings/0001213900-25-046124.md) | [(0.34)](/filings/0001213900-25-078177.md) | [(1.49)](/filings/0001213900-25-111013.md) | not reported | [0.12](/filings/0001213900-26-057059.md) | [(0.19)](/filings/0001213900-26-087946.md) | [0.03](/filings/0001213900-25-111013.md) | not reported | [(0.09)](/filings/0001213900-26-057059.md) | [(0.08)](/filings/0001213900-26-087946.md) | - Revenue: us-gaap:Revenues - Cost of revenue: us-gaap:CostOfGoodsAndServicesSold - Gross profit: us-gaap:GrossProfit - Research and development: us-gaap:ResearchAndDevelopmentExpense - Operating income: us-gaap:OperatingIncomeLoss - Interest expense: us-gaap:InterestExpenseNonoperating - Net income: us-gaap:NetIncomeLoss - Diluted EPS: us-gaap:EarningsPerShareDiluted - Basic EPS: us-gaap:EarningsPerShareBasic ## Balance sheet | Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Cash and equivalents | $m | [0.1](/filings/0001213900-24-019042.md) | [6.0](/filings/0001213900-25-032215.md) | [0.0](/filings/0001213900-24-045245.md) | [0.0](/filings/0001213900-24-077054.md) | not reported | [1.7](/filings/0001213900-25-032215.md) | [0.2](/filings/0001213900-25-046124.md) | [0.2](/filings/0001213900-25-078177.md) | [1.1](/filings/0001213900-25-111013.md) | [0.1](/filings/0001213900-26-087946.md) | [1.6](/filings/0001213900-26-057059.md) | [0.9](/filings/0001213900-26-087946.md) | | Current assets | $m | [0.1](/filings/0001213900-24-019042.md) | [14.0](/filings/0001213900-25-032215.md) | [0.1](/filings/0001213900-24-045245.md) | [0.3](/filings/0001213900-24-077054.md) | [38.2](/filings/0001213900-24-100269.md) | [14.9](/filings/0001213900-26-043667.md) | [13.7](/filings/0001213900-25-046124.md) | [15.2](/filings/0001213900-25-078177.md) | [16.3](/filings/0001213900-25-111013.md) | [15.6](/filings/0001213900-26-087946.md) | [17.1](/filings/0001213900-26-057059.md) | [16.4](/filings/0001213900-26-087946.md) | | Total assets | $m | [35.2](/filings/0001213900-24-019042.md) | [20.8](/filings/0001213900-25-032215.md) | [36.2](/filings/0001213900-24-045245.md) | [36.7](/filings/0001213900-24-077054.md) | [45.0](/filings/0001213900-24-100269.md) | [21.1](/filings/0001213900-26-043667.md) | [20.0](/filings/0001213900-25-046124.md) | [28.6](/filings/0001213900-25-078177.md) | [29.5](/filings/0001213900-25-111013.md) | [28.2](/filings/0001213900-26-087946.md) | [29.9](/filings/0001213900-26-057059.md) | [30.1](/filings/0001213900-26-087946.md) | | Current liabilities | $m | [6.5](/filings/0001213900-24-019042.md) | [32.2](/filings/0001213900-25-032215.md) | [9.0](/filings/0001213900-24-045245.md) | [8.4](/filings/0001213900-24-077054.md) | [21.0](/filings/0001213900-24-100269.md) | [20.1](/filings/0001213900-26-043667.md) | [25.4](/filings/0001213900-25-046124.md) | [31.6](/filings/0001213900-25-078177.md) | [28.4](/filings/0001213900-25-111013.md) | [31.8](/filings/0001213900-26-087946.md) | [15.1](/filings/0001213900-26-057059.md) | [10.4](/filings/0001213900-26-087946.md) | | Total liabilities | $m | [7.3](/filings/0001213900-24-019042.md) | [32.3](/filings/0001213900-25-032215.md) | [13.9](/filings/0001213900-24-045245.md) | [9.5](/filings/0001213900-24-077054.md) | [53.0](/filings/0001213900-24-100269.md) | [38.1](/filings/0001213900-26-043667.md) | [31.7](/filings/0001213900-25-046124.md) | [39.5](/filings/0001213900-25-078177.md) | [33.7](/filings/0001213900-25-111013.md) | [38.0](/filings/0001213900-26-087946.md) | [24.8](/filings/0001213900-26-057059.md) | [22.0](/filings/0001213900-26-087946.md) | | Long-term debt | $m | not reported | [23.9](/filings/0001213900-25-032215.md) | not reported | [12.7](/filings/0001213900-24-100269.md) | not reported | [12.8](/filings/0001213900-25-046124.md) | [14.3](/filings/0001213900-25-046124.md) | not reported | not reported | not reported | [5.0](/filings/0001213900-26-057059.md) | [10.6](/filings/0001213900-26-087946.md) | | Short-term borrowings | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Shareholders' equity | $m | [(26.5)](/filings/0001213900-24-100269.md) | [(11.5)](/filings/0001213900-26-043667.md) | [(5.0)](/filings/0001213900-24-100269.md) | [(11.7)](/filings/0001213900-24-100269.md) | [(8.0)](/filings/0001213900-24-100269.md) | [(17.0)](/filings/0001213900-26-087946.md) | [(11.7)](/filings/0001213900-26-087946.md) | [(10.9)](/filings/0001213900-26-087946.md) | [(4.3)](/filings/0001213900-25-111013.md) | [(9.8)](/filings/0001213900-26-087946.md) | [5.0](/filings/0001213900-26-087946.md) | [8.1](/filings/0001213900-26-087946.md) | - Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue, us-gaap:Cash - Current assets: us-gaap:AssetsCurrent - Total assets: us-gaap:Assets - Current liabilities: us-gaap:LiabilitiesCurrent - Total liabilities: us-gaap:Liabilities - Long-term debt: us-gaap:LongTermDebt - Short-term borrowings: not reported - Shareholders' equity: us-gaap:StockholdersEquity ## Cash flow | Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Operating cash flow | $m | [(6.7) d](/filings/0001213900-24-100269.md) | [(5.5) d](/filings/0001213900-25-032215.md) | [(10.7)](/filings/0001213900-25-046124.md) | [(4.3) d](/filings/0001213900-25-078177.md) | [(4.8) d](/filings/0001213900-25-111013.md) | [(5.8) d](/filings/0001213900-26-043667.md) | [(3.7)](/filings/0001213900-26-057059.md) | [(3.4) d](/filings/0001213900-26-087946.md) | [(4.4) d](/filings/0001213900-25-111013.md) | [(3.7) d](/filings/0001213900-26-043667.md) | [(5.2)](/filings/0001213900-26-057059.md) | [(5.9) d](/filings/0001213900-26-087946.md) | | Capital expenditure | $m | not reported | [0.0 d](/filings/0001213900-25-032215.md) | [0.0](/filings/0001213900-25-046124.md) | [0.0 d](/filings/0001213900-25-078177.md) | [0.0 d](/filings/0001213900-25-111013.md) | [0.0 d](/filings/0001213900-26-043667.md) | not reported | not reported | not reported | not reported | not reported | not reported | | Share repurchases | $m | [21.1 d](/filings/0001213900-24-019042.md) | [0.0 d](/filings/0001213900-24-019042.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | - Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities - Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment - Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock ## Shares | Line item | Unit | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Diluted shares (weighted) | millions of shares | [16.4](/filings/0001213900-24-100269.md) | [21.1](/filings/0001213900-25-046124.md) | [21.3](/filings/0001213900-25-078177.md) | [22.3](/filings/0001213900-25-111013.md) | [36.6](/filings/0001213900-26-057059.md) | [38.8](/filings/0001213900-26-087946.md) | [45.7](/filings/0001213900-25-111013.md) | [50.5](/filings/0001213900-26-057059.md) | [52.0](/filings/0001213900-26-087946.md) | - Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding Shares outstanding: 62,214,156 at 2026-08-10, from the cover of the [10-Q filed 2026-08-12](/filings/0001213900-26-087946.md) (dei:EntityCommonStockSharesOutstanding). Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:49 ET. No prices; not investment advice.